Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCSINS oral snake venom metalloproteinase inhibitor trial
PACTR202607586137371Phase 2Not yet recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Jan 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of Dimaval and marimastat in snakebite envenomation (2 arms), sponsored by Liverpool School of Tropical Medicine. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Dimavalmarimastat
03
Conditions
snakebite envenomation
Beyond the preview
Go deeper on PACTR202607586137371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607586137371.